Aristotle Capital Boston LLC lessened its holdings in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,030,031 shares of the company's stock after selling 99,948 shares during the period. Aristotle Capital Boston LLC owned approximately 1.02% of Herbalife worth $6,891,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HLF. Vanguard Group Inc. boosted its holdings in Herbalife by 7.5% in the fourth quarter. Vanguard Group Inc. now owns 11,271,417 shares of the company's stock worth $75,406,000 after acquiring an additional 785,574 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Herbalife by 9.9% in the 4th quarter. Renaissance Technologies LLC now owns 7,088,868 shares of the company's stock worth $47,425,000 after purchasing an additional 638,567 shares in the last quarter. Long Focus Capital Management LLC increased its stake in Herbalife by 27.3% during the 4th quarter. Long Focus Capital Management LLC now owns 4,758,127 shares of the company's stock valued at $31,832,000 after purchasing an additional 1,020,127 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Herbalife by 777.0% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,987,490 shares of the company's stock worth $19,986,000 after buying an additional 2,646,848 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Herbalife by 8.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,696,560 shares of the company's stock valued at $18,040,000 after buying an additional 216,603 shares during the last quarter.
Herbalife Stock Up 3.8 %
Shares of HLF traded up $0.26 during mid-day trading on Thursday, reaching $7.05. The company had a trading volume of 1,028,223 shares, compared to its average volume of 2,261,130. The stock has a 50 day moving average of $7.65 and a two-hundred day moving average of $7.25. The stock has a market capitalization of $718.02 million, a P/E ratio of 2.83, a PEG ratio of 0.29 and a beta of 0.88. Herbalife Ltd. has a 52-week low of $5.04 and a 52-week high of $12.79.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $0.59 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.19. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. The business had revenue of $1.22 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter last year, the company earned $0.49 EPS. The business's revenue was down 3.4% on a year-over-year basis. On average, sell-side analysts expect that Herbalife Ltd. will post 1.57 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on HLF shares. StockNews.com lowered Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, April 29th. DA Davidson upgraded Herbalife from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $7.50 to $14.00 in a research note on Friday, March 21st. Finally, Citigroup cut their price target on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Herbalife has a consensus rating of "Moderate Buy" and a consensus target price of $11.50.
Read Our Latest Stock Analysis on HLF
Insiders Place Their Bets
In other Herbalife news, Director Juan Miguel Mendoza purchased 5,000 shares of Herbalife stock in a transaction that occurred on Friday, May 2nd. The stock was bought at an average price of $6.73 per share, with a total value of $33,650.00. Following the acquisition, the director now owns 140,000 shares of the company's stock, valued at $942,200. This trade represents a 3.70 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders bought 12,500 shares of company stock worth $94,900. Company insiders own 1.73% of the company's stock.
About Herbalife
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Stories
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
